An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen

Authors: Parsey K.S.1; Pong A.

Source: Contraception, Volume 61, Number 2, February 2000 , pp. 105-111(7)

Publisher: Elsevier

Keywords: Yasmin; drospirenone; oral contraceptive; ethinyl estradiol; efficacy; cycle control; menstrual distress questionnaire

Language: English

Document Type: Research article

DOI: 10.1016/S0010-7824(00)00083-4

Affiliations: 1: *Berlex Laboratories, Montville, New Jersey, USA

Links for this article